Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 2Recruiting 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 3Head & Neck 2Gynecologic 2Dermatologic 2Breast 2Thoracic 1Sarcoma 1Genitourinary 1CNS 1

Conditions

Sarcoma 266Osteosarcoma 81Sarcoma, Ewing 51Melanoma 44Neoplasms 43Gastrointestinal Stromal Tumors 41Colorectal Neoplasms 39Breast Neoplasms 38Rhabdomyosarcoma 36Bone Neoplasms 36Ovarian Neoplasms 32Neoplasm Metastasis 32Neuroblastoma 30Pancreatic Neoplasms 29Stomach Neoplasms 27Dendritic Cell Sarcoma, Interdigitating 27Lung Neoplasms 26Liposarcoma 26Leiomyosarcoma 26Glioblastoma 23Uterine Cervical Neoplasms 22Sarcoma, Synovial 22Head and Neck Neoplasms 22Carcinoma, Non-Small-Cell Lung 22Esophageal Neoplasms 21Lymphoma 19Sarcoma, Kaposi 18Prostatic Neoplasms 18Carcinoma, Hepatocellular 18Urinary Bladder Neoplasms 17

Interventions

Surgical Procedures, Operative 1Radiotherapy 1Ifosfamide 1Doxorubicin 1Diathermy 1Dacarbazine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Hyperthermia × Sarcoma × Clear all
NCT06835049 2025-12-30

TNT-HYPE

Swiss Cancer Institute

Phase 2 Recruiting
24 enrolled
Sarcoma

Hyperthermia, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡